National and Kapodistrian University of Athens
Η κλινική σημασία της ανίχνευσης κυκλοφορούντων καρκινικών κυττάρων με multiplex PCR σε ασθενείς με καρκίνο της ουροδόχου κύστης
Abstract
dc:descriptionBladder cancer is the most common malignancy of the urinary tract and a leading cause of cancer morbidity and mortality.The standard procedure for diagnosing bladder cancer includes cystoscopy combined with cytological examination. Cystoscopy is an invasive, high-cost method and is considered the gold standard for detecting and monitoring bladder tumors, with a low sensitivity, whereas cytology is a low-sensitive operator-dependent method.There is a need for sensitive and specific non-invasive urinary markers that might reduce both cystoscopy and cost. Several markers are commercially available but none of them alone is sensitive and specific. An ideal bladder cancer marker should have high sensitivity and specificity, it should be non-invasive and easy to interpret.The presence of circulating tumor cells (CTCs) in the peripheral blood was first reported by Ashworth in 1869. Malignant cells are detached from primary tumors and become invasive. These cells may then intravasate into the blood or lymphatic circulation and subsequently extravasate from the circulation and establish a secondary tumor in another organ far from the primary tumor. The detection of CTCs has been well-demonstrated in many other malignancies. CTC detection could contribute to tumor diagnosis and identify patients with advanced bladder cancer. Polymerase chain reaction (PCR)-based methods are commonly used rapid and low-cost methods for the detection of CTCs.The aim of this study was the development of a multiplex- PCR assay for the detection of CTCs in patients with bladder cancer using primers for CK19, CK20, EGFR in peripheral blood, and SURVIVIN, hTERT and CK20 in urine samples, and to assess its potential use for clinical applications in bladder cancer patients. After a significant period of follow-up, we were able to assess a number of statistical values (sensitivity, specificity, positive and negative predictive values, progression-free and recurrence-free survival) and their potential clinical and predictive role.A total of 208 patients (177 men and 31 women) from one tertiary University Hospital, prior to surgical or any other therapeutic intervention were enrolled in the study. They were categorized into three groups. Group one included patients newly- diagnosed with bladder cancer (n=105), group two included patients with history of bladder cancer (n=64), and group three included healthy volunteers (n=39).Multiplex RT-PCR assay can provide useful information concerning bladder cancer stage, grading and progression- free and recurrence-free survival. The combination of the mRNA markers in a single reaction could be beneficial in the early detection of high-grade/clinically relevant disease and monitoring of bladder cancer patients (mainly those with high possibility to progress or recurrence), as it has previously been documented in other malignancies.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Leotsakos, Ioannis
- Λεωτσάκος, Ιωάννης
Subjects
dc:subject × 9Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40098